Opus Genetics, Inc. Increase (Decrease) in Accounts Payable and Accrued Liabilities
Opus Genetics, Inc. (IRD) reported Increase (Decrease) in Accounts Payable and Accrued Liabilities of $992.75 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-10-29.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities · last filed 2020-10-29
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-09-30 was $67.73K.
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-06-30 was $953.75K.
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2020-03-31 was -$28.72K.
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for the quarter ending 2019-12-31 was -$100.48K.
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2019 was -$1.89M.
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2018 was -$81.38K, a 106.02% decline from fiscal 2017.
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2017 was $1.35M.
- Opus Genetics, Inc. increase (decrease) in accounts payable and accrued liabilities for fiscal 2016 was -$778.80K, a 485.48% decline from fiscal 2015.
| Period end | Increase (Decrease) in Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 12 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 132 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 135 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 138 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 141 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 144 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 147 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 150 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 153 month | Increase (Decrease) in Accounts Payable and Accrued Liabilities 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-09-30 | $67.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $1.02M derived: sum of 2 quarters · filed 2020-10-29 | $992.75K 10-Q · filed 2020-10-29 | $892.27K derived: sum of 4 quarters · filed 2020-10-29 | |||||||||
| 2020-06-30 | $953.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $925.02K 10-Q · filed 2020-08-14 | $824.54K derived: sum of 3 quarters · filed 2020-08-14 | $270.02K derived: sum of 4 quarters · filed 2020-10-29 | |||||||||
| 2020-03-31 | -$28.72K 10-Q · filed 2020-05-07 | -$129.21K derived: sum of 2 quarters · filed 2020-05-07 | -$683.73K derived: sum of 3 quarters · filed 2020-10-29 | -$1.01M derived: sum of 4 quarters · filed 2020-10-29 | |||||||||
| 2019-12-31 | -$100.48K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$655.00K derived: sum of 2 quarters · filed 2020-10-29 | -$980.47K derived: sum of 3 quarters · filed 2020-10-29 | -$1.89M 10-K · filed 2020-02-21 | |||||||||
| 2019-09-30 | -$554.52K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$879.99K derived: sum of 2 quarters · filed 2020-10-29 | -$1.79M 10-Q · filed 2020-10-29 | -$1.97M derived: sum of 4 quarters · filed 2020-10-29 | |||||||||
| 2019-06-30 | -$325.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | -$1.23M 10-Q · filed 2020-08-14 | -$1.41M derived: sum of 3 quarters · filed 2020-08-14 | -$1.46M derived: sum of 4 quarters · filed 2020-08-14 | |||||||||
| 2019-03-31 | -$906.35K 10-Q · filed 2020-05-07 | -$1.09M derived: sum of 2 quarters · filed 2020-05-07 | -$1.14M derived: sum of 3 quarters · filed 2020-05-07 | -$802.82K derived: sum of 4 quarters · filed 2020-05-07 | |||||||||
| 2018-12-31 | -$179.10K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-21 | -$229.14K derived: sum of 2 quarters · filed 2020-02-21 | $103.53K derived: sum of 3 quarters · filed 2020-02-21 | -$81.38K 10-K · filed 2020-02-21 | |||||||||
| 2018-09-30 | -$50.05K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $282.63K derived: sum of 2 quarters · filed 2019-11-06 | $97.72K 10-Q · filed 2019-11-06 | $992.87K derived: sum of 4 quarters · filed 2019-11-06 | |||||||||
| 2018-06-30 | $332.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $147.77K 10-Q · filed 2019-08-07 | $1.04M derived: sum of 3 quarters · filed 2019-08-07 | $1.58M derived: sum of 4 quarters · filed 2019-08-07 | |||||||||
| 2018-03-31 | -$184.91K 10-Q · filed 2019-05-10 | $710.24K derived: sum of 2 quarters · filed 2019-05-10 | $1.25M derived: sum of 3 quarters · filed 2019-05-10 | $1.33M derived: sum of 4 quarters · filed 2019-05-10 | |||||||||
| 2017-12-31 | $895.15K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $1.43M derived: sum of 2 quarters · filed 2019-03-07 | $1.52M derived: sum of 3 quarters · filed 2019-03-07 | $1.35M 10-K · filed 2019-03-07 | |||||||||
| 2017-09-30 | $534.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $623.29K derived: sum of 2 quarters · filed 2018-11-02 | $456.28K 10-Q · filed 2018-11-02 | $553.05K derived: sum of 4 quarters · filed 2018-11-02 | |||||||||
| 2017-06-30 | $88.52K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | -$78.49K 10-Q · filed 2018-08-03 | $18.28K derived: sum of 3 quarters · filed 2018-08-03 | $9.36K derived: sum of 4 quarters · filed 2018-08-03 | |||||||||
| 2017-03-31 | -$167.01K 10-Q · filed 2018-05-04 | -$70.24K derived: sum of 2 quarters · filed 2018-05-04 | -$79.16K derived: sum of 3 quarters · filed 2018-05-04 | -$1.57M derived: sum of 4 quarters · filed 2018-05-04 | |||||||||
| 2016-12-31 | $96.78K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $87.85K derived: sum of 2 quarters · filed 2018-03-09 | -$1.40M derived: sum of 3 quarters · filed 2018-03-09 | -$778.80K 10-K · filed 2018-03-09 | |||||||||
| 2016-09-30 | -$8.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | -$1.50M derived: sum of 2 quarters · filed 2017-11-03 | -$875.57K 10-Q · filed 2017-11-03 | -$1.45M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-06-30 | -$1.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-04 | -$866.65K 10-Q · filed 2017-08-04 | -$1.44M derived: sum of 3 quarters · filed 2018-03-09 | -$1.37M derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2016-03-31 | $622.97K 10-Q · filed 2017-05-03 | $46.20K derived: sum of 2 quarters · filed 2018-03-09 | $115.46K derived: sum of 3 quarters · filed 2018-03-09 | $534.73K derived: sum of 4 quarters · filed 2018-03-09 | |||||||||
| 2015-12-31 | -$576.76K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | -$507.51K derived: sum of 2 quarters · filed 2018-03-09 | -$88.24K derived: sum of 3 quarters · filed 2018-03-09 | $202.03K 10-K · filed 2018-03-09 | |||||||||
| 2015-09-30 | $69.25K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-04 | $488.52K derived: sum of 2 quarters · filed 2016-11-04 | $778.80K 10-Q · filed 2016-11-04 | $1.51M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||
| 2015-06-30 | $419.27K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $709.54K 10-Q · filed 2016-08-05 | $1.44M derived: sum of 3 quarters · filed 2017-02-24 | $1.63M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||
| 2015-03-31 | $290.28K 10-Q · filed 2016-05-06 | $1.02M derived: sum of 2 quarters · filed 2017-02-24 | $1.21M derived: sum of 3 quarters · filed 2017-02-24 | $1.87M derived: sum of 4 quarters · filed 2017-02-24 | |||||||||
| 2014-12-31 | $733.75K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24 | $919.41K derived: sum of 2 quarters · filed 2017-02-24 | $1.58M derived: sum of 3 quarters · filed 2017-02-24 | $1.53M 10-K · filed 2017-02-24 | |||||||||
| 2014-09-30 | $185.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | $847.01K derived: sum of 2 quarters · filed 2015-11-02 | $791.75K 10-Q · filed 2015-11-02 | $975.27K derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-06-30 | $661.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $606.09K 10-Q · filed 2015-08-07 | $789.61K derived: sum of 3 quarters · filed 2016-03-14 | $919.78K derived: sum of 4 quarters · filed 2016-03-14 | |||||||||
| 2014-03-31 | -$55.26K 10-Q · filed 2015-05-08 | $128.26K derived: sum of 2 quarters · filed 2016-03-14 | $258.43K derived: sum of 3 quarters · filed 2016-03-14 | -$97.67K derived: sum of 4 quarters · filed 2016-03-14 | $878.50K 10-Q · filed 2014-05-14 | ||||||||
| 2013-12-31 | $183.52K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $313.69K derived: sum of 2 quarters · filed 2016-03-14 | -$42.41K derived: sum of 3 quarters · filed 2016-03-14 | $81.92K 10-K · filed 2016-03-14 | $933.76K 10-K · filed 2014-03-21 | ||||||||
| 2013-09-30 | $130.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$225.92K derived: sum of 2 quarters · filed 2014-11-12 | -$101.59K 10-Q · filed 2014-11-12 | -$121.27K derived: sum of 4 quarters · filed 2014-11-12 | $750.24K 10-Q · filed 2013-11-13 | ||||||||
| 2013-06-30 | -$356.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$231.77K 10-Q · filed 2014-08-13 | -$251.44K derived: sum of 3 quarters · filed 2014-08-13 | -$270.90K derived: sum of 4 quarters · filed 2014-08-13 | $620.07K 10-Q · filed 2013-08-12 | ||||||||
| 2013-03-31 | $124.33K 10-Q · filed 2014-05-14 | $104.66K derived: sum of 2 quarters · filed 2014-05-14 | $85.20K derived: sum of 3 quarters · filed 2014-05-14 | -$43.84K derived: sum of 4 quarters · filed 2014-05-14 | $976.17K 10-Q · filed 2013-05-09 | ||||||||
| 2012-12-31 | -$19.67K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-21 | -$39.13K derived: sum of 2 quarters · filed 2014-03-21 | -$168.17K derived: sum of 3 quarters · filed 2014-03-21 | -$333.57K 10-K · filed 2014-03-21 | $851.84K 10-K · filed 2013-03-22 | ||||||||
| 2012-09-30 | -$19.46K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$148.50K derived: sum of 2 quarters · filed 2013-11-13 | -$313.90K 10-Q · filed 2013-11-13 | -$3.03M derived: sum of 4 quarters · filed 2013-11-13 | $871.51K 10-Q · filed 2012-11-08 | ||||||||
| 2012-06-30 | -$129.04K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | -$294.44K 10-Q · filed 2013-08-12 | -$3.01M derived: sum of 3 quarters · filed 2013-08-12 | -$3.00M derived: sum of 4 quarters · filed 2013-08-12 | $890.97K 10-Q · filed 2012-08-08 | ||||||||
| 2012-03-31 | -$165.39K 10-Q · filed 2013-05-09 | -$2.89M derived: sum of 2 quarters · filed 2013-05-09 | -$2.87M derived: sum of 3 quarters · filed 2013-05-09 | -$1.92M derived: sum of 4 quarters · filed 2013-05-09 | $1.02M 10-Q · filed 2012-05-09 | ||||||||
| 2011-12-31 | -$2.72M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-22 | -$2.71M derived: sum of 2 quarters · filed 2013-03-22 | -$1.75M derived: sum of 3 quarters · filed 2013-03-22 | -$635.50K 10-K · filed 2013-03-22 | |||||||||
| 2011-09-30 | $13.84K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $965.83K derived: sum of 2 quarters · filed 2012-11-08 | $2.08M 10-Q · filed 2012-11-08 | $2.56M derived: sum of 4 quarters · filed 2012-11-08 | |||||||||
| 2011-06-30 | $951.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-08 | $2.07M 10-Q · filed 2012-08-08 | $2.55M derived: sum of 3 quarters · filed 2012-08-08 | $2.28M derived: sum of 4 quarters · filed 2012-08-08 | |||||||||
| 2011-03-31 | $1.12M 10-Q · filed 2012-05-09 | $1.60M derived: sum of 2 quarters · filed 2012-05-09 | $1.33M derived: sum of 3 quarters · filed 2012-05-09 | ||||||||||
| 2010-12-31 | $479.73K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-16 | $210.96K derived: sum of 2 quarters · filed 2012-03-16 | $1.03M 10-K · filed 2012-03-16 | ||||||||||
| 2010-09-30 | -$268.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-09 | $555.27K 10-Q · filed 2011-11-09 | |||||||||||
| 2010-06-30 | $824.03K 10-Q · filed 2011-08-09 | ||||||||||||
| 2009-12-31 | $427.01K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |